Nuvectis Pharma, Inc. (NVCT)
USD 4.7
(-8.02%)
USD 4.7
(-8.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -15.95 Million | -13.55 Million | -9.5 Million | 24 Thousand |
| Net Income | -22.26 Million | -19.08 Million | -12.89 Million | -24 Thousand |
| Depreciation & Amortization | - | - | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 4.7 Million | 1.7 Million | 1.89 Million | - |
| Change in working capital | 1.6 Million | 3.81 Million | 1.49 Million | 10 Thousand |
| Other non-cash items | 4.84 Million | -2.43 Million | 307 Thousand | 24 Thousand |
| Investing Cash Flow | - | - | - | - |
| Investments in PPE | - | - | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | 15.08 Million | 27.81 Million | 15.24 Million | - |
| Debt repayment | - | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 15.08 Million | 31.87 Million | 15.24 Million | - |
| Other Financing Activities | -1.39 Million | -4.06 Million | 15.24 Million | - |
| Accounts receivables | - | - | - | - |
| Accounts payables | -139 Thousand | 4.13 Million | 1.58 Million | - |
| Inventory | - | - | - | - |
| Other working capital | 1.74 Million | -320.99 Thousand | -91 Thousand | 10 Thousand |
| Cash at beginning of period | 19.99 Million | 5.74 Million | - | - |
| Cash at end of period | 19.12 Million | 19.99 Million | 5.74 Million | 24 Thousand |
| Capital Expenditure | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | -867 Thousand | 14.25 Million | 5.74 Million | 24 Thousand |
| Free Cash Flow | -15.95 Million | -13.55 Million | -9.5 Million | 24 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.15 Million | -4.42 Million | -4.17 Million | -22.26 Million | -6.62 Million | -5.88 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | -2.58 Million | 1.26 Million | 1.29 Million | 4.7 Million | 1.22 Million | 1.13 Million |
| Change in working capital | 1.33 Million | 146 Thousand | -1.48 Million | 1.6 Million | 1.55 Million | 1.5 Million |
| Other non-cash items | 2.99 Million | 1.17 Million | 2.3 Million | 4.84 Million | 1.19 Million | 1.13 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.45 Million | 1.67 Million | 4.69 Million | 15.08 Million | 917 Thousand | 703 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -6.36 Million | 1.67 Million | 4.69 Million | 15.08 Million | 917 Thousand | 1.12 Million |
| Other Financing Activities | 7.82 Million | -55 Thousand | -153 Thousand | -1.39 Million | 16 Thousand | -423 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 415 Thousand | 87 Thousand | -1.01 Million | -139 Thousand | 21 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 412 Thousand | 59 Thousand | -471 Thousand | 1.74 Million | 1.53 Million | 1.5 Million |
| Cash at beginning of period | 18.11 Million | 19.46 Million | 19.12 Million | 19.99 Million | 22.05 Million | 24.6 Million |
| Cash at end of period | 17.16 Million | 18.11 Million | 19.46 Million | 19.12 Million | 19.12 Million | 22.05 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -947 Thousand | -1.34 Million | 338 Thousand | -867 Thousand | -2.93 Million | -2.54 Million |
| Free Cash Flow | -2.4 Million | -3.02 Million | -4.35 Million | -15.95 Million | -3.85 Million | -3.24 Million |
000959
PUCK
PSCO
TRJA
SNA
MEL